Workflow
华恒生物: 安徽华恒生物科技股份有限公司关于聘请H股发行并上市审计机构的公告

Core Viewpoint - Anhui Huaheng Biological Technology Co., Ltd. plans to appoint RSM Hong Kong as the auditing firm for its H-share issuance and listing on the Hong Kong Stock Exchange [1][2]. Group 1: Appointment of Auditing Firm - The company intends to hire RSM Hong Kong as the auditing institution for its H-share listing [1]. - RSM Hong Kong is a limited liability accounting firm established in Hong Kong in 2008, providing audit, tax, and consulting services to clients globally [1][2]. - RSM Hong Kong is registered as a public interest entity auditor under Hong Kong law and has not faced any criminal or administrative penalties in the past five years [2]. Group 2: Audit Fee Determination - The audit fee will be determined based on the complexity and requirements of the H-share issuance and listing, as well as the expertise and experience of the staff involved [2]. Group 3: Approval Process - The Audit Committee of the company has reviewed and approved the appointment of RSM Hong Kong, confirming its qualifications and independence [2][3]. - The Supervisory Board also approved the appointment of RSM Hong Kong for the H-share listing [3]. - The Board of Directors has agreed to propose the appointment to the shareholders' meeting for final approval [3][4].